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Mitochondrion is considered as the “powerhouse of the 
cell” almost immediately since its discovery. It carries less 
than 1,000 proteins and some nucleotides as well as lipids. 
Mitochondrion is also discovered as the “lung of the cell” 
for its role in cellular respiration. As the important cellular 
organelle, there are many metabolic processes occurred in 
mitochondria.  
The mammalian target of repamycin (mTOR), or 
FKBP12-rapamycin associated protein 1 (FRAP1), is a 
highly conserved protein kinase which contains 2,549 ami-
no acids. More and more evidence show that mTOR can 
shuttle to mitochondria and play some role in cell metabo-
lism. Just as mentioned above, mTOR can regulate different 
metabolic products synthesis with post-translational modi-
fication, mainly phosphorylation of mTOR itself and its 
down-stream protein [1].  
Metabolism is found greatly conducted by mTOR sig-
naling pathway since mTOR was identified in 1990s. It can 
influence protein synthesis, lipid biogenesis and energy 
regulation. The metabolites provide signals of cellular nu-
trient state and trigger different response on mTOR path-
way. Accompany with other components, mTOR construct 
two different protein complexes, mTORC1 (mTOR com-
plex 1) and mTORC2. The mTORC1 is composed of 
mTOR, Raptor, GL mLST8, (mammalian lethal with 
SEC13 protein 8), Deptor and PRAS40 (a 40 kD Pro-rich 
Akt substrate). mTORC2 consists of mTOR, Raptor, GL 
(mLST8), RICTOR (rapamycin-insensitive companion of 
mTOR), mSIN1 (SAPK-interacting protein 1), PRR5 (pro-
line rich protein 5) and PRR5L (proline rich protein 5-like), 
which were also known as Protor1 and Protor2 [2]. Both of 
the two mTOR complex play critical role in biological pro-
cess. 
Protein post-translational modification is an important 
method to control or regulate the protein function after its 
synthesis. Protein function is regulated by adding different 
organic groups, such as methyl group, acetyl group, phos-
phate group and ubiquitin, on the side chain of amino acid 
of the protein. These modifications could change the surface 
charge or the 3D structure of the protein which could inter-
fere the protein-protein interaction. In cells, these modifica-
tions are usually through enzymatic reaction. In mTOR 
case, the protein itself can be phosphorylated at multiple 
sites. And also, mTOR can regulate its substrates and down-
stream molecules by post translation modification such as 
phosphorylation, acetylation and ubiquitination [3,4]. With 
these modification, mTOR can manipulate several bio-
chemistry process happened in mitochondria and critical for 
cell metabolism. 
ATP (adenosine triphosphate) synthesis is the most im-
portant mitochondrial function which would supply the en-
ergy that the cell need. As an energy sensor, mTOR is di-
rectly regulated by cellular ATP concentration, which trig-
gers AMPK (AMP-activated protein kinase)/mTOR path-
way to regulate the intracellular ATP level. In this regula-
tion, phosphorylation plays a critical role. During fasting, 
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the ratio of ATP:ADP drops, AMPK is activated and in-
duces TSC2 (tuberous sclerosis 2) phosphorylation, which 
increases the GAP (GTPase-activating protein) activity of 
TSC2 towards Rheb and reduces mTORC1 activation [5]. 
In other way, AMPK can inhibit mTORC1 activity by 
phosphorylated Raptor, the subunit of mTORC1, when 
there is an energy shortage [6]. The mTORC1 can also in-
crease oxidative respiration by phosphorylating STAT3 
(signal transducer and activator of transcription 3). Recent-
ly, there are direct evidences show that mTORC1 regulates 
ATP production in mitochondria through 4E-BP phosphor-
ylation [7]. Besides that, mTOR can regulate insulin sensi-
tivity, which controls the glucose level in the cells, by 
phosphorylation and downstream phosphorylation. In mice, 
overexpression of hNAG-1 (human non-steroidal anti-  
inflammatory drug-activated gene-1) would reduce mTOR 
phosphorylation at serin2884, which leads the improvement 
of insulin sensitivity [8]. In another hand, glucose uptake is 
inhibited by knock-down of a small peptide Nesfatin-1,  
and this peptide would also increase mTOR S2884 phos-
phorylation and induce STAT3 phosphorylation at Y705 
and S727 [9]. With all these findings, we can conclude that 
phosphorylation of mTOR and its downstream molecules 
can regulate oxidative respiration in mitochondria and ATP 
generation. 
Acetyl-CoA is produced in mitochondria during the TCA 
cycle and oxidation of pyruvate. As an important metabo-
lite, Acetyl-CoA conveys the carbon atoms within the acetyl 
group to the citric acid cycle (Krebs cycle) to be oxidized 
for energy production. Acetyl-CoA is catalyzed into malo-
nyl-CoA by acetyl-CoA carboxylase (ACC), at which point 
malonyl-CoA is destined to feed into the fatty acid synthesis 
pathway [10].  
The mTOR can regulate the activity of some vital en-
zymes in acetyl-CoA synthesis along with lipid generation. 
Though mTOR has no effect on the Acetyl-CoA synthetic 
process in mitochondria, it can regulate the downstream 
reaction in which acetyl-CoA would take part. mTOR activ-
ity could increase the synthetic rates of ACC and fatty 
acid synthase (FSN) [11]. The mTORC1 could activate 
SREBP-1 (sterol regulatory element-binding protein 1) by 
S6K1 dependent and independent manner [12]. In S6K1 
independent SREBP-1 regulation of Acetyl-CoA synthesis, 
Lipin-1 was phosphorylated and inhibited. LIPIN1 is a 
phosphatidic acid phosphatase which could inhibit 
SREBP-1. The mTORC1 can directly phosphorylate 
LIPIN1 and inhibit its activity [13]. Thus mTORC1 can 
affect the Acetyl-CoA synthesis indirectly through Lipin-1 
phosphorylation. 
As was shown, in de novo lipogenesis, Acetyl-CoA’s 
concentration is regulated by PI3K/Akt/mTOR pathway, 
and this regulation is strongly driven by insulin [14]. Insulin 
could induced Akt phosphorylation through insulin    
receptor. The activated Akt would induce the expression of 
genes which are involved in lipogenesis [15]. There are re-
ports showed that SREBP-1, which was mentioned above, 
could also regulated by Akt and play some role in lipogene-
sis [16,17]. 
We could draw the conclusion that mTOR could regulate 
ATP and Acetyl-CoA synthesis in mitochondria with post 
translational regulation, usually phosphorylation. There 
were some evidence shown mTOR could regulate cell me-
tabolism by acetylation-deacetylation process on down- 
stream molecules, though there are no published report 
which support this. By control the ATP and Acetyl-CoA 
synthesis, mTOR would dominant the cellular energy re-
source and regulate multiple enzyme catalysis which was 
extremely important for cell metabolism. So, we could re-
gard mTOR in mitochondria as an arsenal of cell metabo-
lism. Through mTOR, many components (free molecular) 
can assemble into different weapons (biomacromolecules) 
and these weapons can help the cells to defense themselves 
and transfer their genetic information.  
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